The Cellular Effects of Physiologic Dosing of DFMO in Neuroblastoma Tumorigenesis
Mulama H. David, Divya Gandra1, Kimberly Q. McKinney, David M. Foureau, Kaitlyn Smith, Jason Haw, Giselle Saulnier Sholler, The Cellular Effects of Physiologic Dosing of DFMO in Neuroblastoma Tumorigenesis, 2022, ASPHO Annual[...]
Utilizing transcriptome analysis to identify targeted therapy for Ewing sarcoma
Smith, K, Gandra, D, McKinney, K, Dykema, K, Nagulapally, A, Mulama, D, Sholler, GS, Oesterheld, J, Trovillion, E. Utilizing transcriptome analysis to identify targeted therapy for Ewing sarcoma. (2022), ASPHO Annual Meeting,[...]
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma
Jacqueline M. Kraveka, Elizabeth C. Lewis, Genevieve Bergendahl, William Ferguson, Javier Oesterheld, Elizabeth Kim, Abhinav B. Nagulapally, Karl J. Dykema, Valerie I. Brown, William D. Roberts, Deanna Mitchell,on E Dslin,[...]
Identification of Let-7 miRNA Activity as a Prognostic Biomarker of SHH Medulloblastoma
Maximillian S Westphal 1, Eunjee Lee 1 2, Eric E Schadt 1 2, Giselle S Sholler 3 4, Jun Zhu, Identification of Let-7 miRNA Activity as a Prognostic Biomarker of SHH[...]
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion
Sara A. Byron*, William P. D. Hendricks*, Abhinav B. Nagulapally*, Jacqueline M. Kraveka, William S. Ferguson, Valerie I. Brown, Don E. Eslin, Deanna Mitchell, Albert Cornelius, William Roberts, Michael S.[...]
Genomic Analysis and Precision Therapy for Recurrent and Resistant Sarcoma
Javier Oesterheld, Abhinav B Nagulapally, Karl Dykema, William Ferguson, Michael Isakoff, Erin Trovillion, Genevieve Bergendahl, Giselle Saulnier Sholler, Genomic Analysis and Precision Therapy for Recurrent and Resistant Sarcoma, ASPHO Annual Meeting,[...]
9-ING-41, a glycogen synthase kinase 3B inhibitor targets TP53 in pediatric brain tumors ATRT and ETMR
Jason L. Haw, Elizabeth M. Moore, Kimberly McKinney, Karl Dykema, Abhinav Nagulapally, Nury Steuerwald, Giselle S. Sholler. 9-ING-41, a glycogen synthase kinase 3B inhibitor targets TP53 in pediatric brain tumors ATRT[...]
A phase 1 dose escalation study of TB-403 in pediatric relapsed or refractory medulloblastoma, neuroblastoma, Ewing sarcoma, or alveolar rhabdomyosarcoma
Giselle L. Saulnier Sholler, Dan G. Duda, Genevieve Bergendahl, David Ebb, Matija Snuderl, Theodore W. Laetsch, Jennifer Michlitsch, Derek Hanson, Michael Isakoff, Kevin Bielamowicz, Jacquline Kraveka, Peter Carmeliet, Andy De[...]
Identification of targeted therapies for treatment of Ewing sarcoma
Smith, K, Gandra, D, McKinney, K, Dykema, K, Nagulapally, A, Sholler, GS, Oesterheld, J, Trovillion, E. Identification of targeted therapies for treatment of Ewing sarcoma [abstract]. In: Proceedings of the 113th Annual[...]
Genomic Comparative Analysis of High Risk Neuroblastoma at Diagnosis and Relapse
Abhinav B Nagulapally, Karl Dykema, Javier Oesterheld, William Ferguson, Michael Isakoff, Erin Trovillion, Genevieve Bergendahl, Giselle Saulnier Sholler, Genomic Comparative Analysis of High Risk Neuroblastoma at Diagnosis and Relapse, ASPHO Annual[...]